Why GMO ETFs
Our exchange-traded funds (ETFs) offer a flexible way of investing in innovative GMO solutions, which are built on nearly 50 years of experience.
Active, TransparentActively managed with daily holdings transparency |
Tax-EfficientTax efficiency for U.S. taxable shareholders from fewer taxable events |
Access and ScalabilityNo minimum size required to invest in long-running GMO strategies |
Our Investment Philosophy
Highly specialized GMO investment teams are grounded in a common belief that a long-term, valuation-based approach will maximize risk-adjusted returns.
We are known for our willingness to challenge the status quo and the creative ways we approach investment problems.
These core philosophies power our singular drive to deliver outstanding long-term investment returns to our clients, including in our ETFs.
GMO ETF LineUp
We are committed to offering investment solutions in the implementation structures that best address investor needs. Our ETF suite offers access to several of GMO’s core investment capabilities where we see compelling opportunities today.
High-Quality Equity |
Value Equity |
Thematic Equity |
Fixed Income |
 |
 |
 |
 |
 |
 |
||
Featured ETF
GMO U.S. Quality ETF
The GMO U.S. Quality ETF (QLTY) surpassed $1 billion in assets in under nine months since launching in November 2023. QLTY leverages GMO’s more than 40 years of quality investing experience to invest in U.S. high-quality stocks.
ETF Research
 |
Beyond the Factor: GMO's Approach to Value InvestingBy Rick Friedman, Catherine LeGraw, and John Thorndike | November 2024GMO has always believed that an objective and disciplined assessment of valuations is critical. We introduce our active, differentiated GMO Value approach, which goes beyond traditional value metrics. |
 |
Quality: The Real McCoyBy Kim Mayer | October 2024Through market cycles and dislocations, high-quality equities have proven to be a stable group of exceptional businesses ideally suited to compounding capital. |
 |
Don't Miss Out: A Historic Opportunity in Deep ValueBy Catherine LeGraw | October 2024In a world where many stocks are being driven ever higher by positive sentiment and investor optimism, some fundamentally sound but unloved companies are trading at extraordinary discounts. |
 |
GMO Quarterly Letter: The Quality AnomalyBy Ben Inker | 4Q 2023Contrary to portfolio theory, investors have historically been able to achieve both higher returns and lower risk by owning the highest quality stocks. |